… In infectious diseases such as myocarditis, the release of endogenous … We report an adult
patient with fulminant myocarditis requiring … mediators after highdose intravenous IgG therapy. …

… A very few cases of fulminant myocarditis in which high-dose intravenous immunoglobulin …
case of fulminant myocarditis in which high-dose intravenous immunoglobulin therapy was …

… fulminant myocarditis, who recovered rapidly after high-dose intravenous immunoglobulin
… [6] showed that high dose of IVIG improved EF in patients with myocarditis and acute dilated …

… fulminant myocarditis (AFM) is a serious heart disease with limited treatment. This observational
retrospective study aimed to investigate whether intravenous immunoglobulin (IVIG… IVIG (…

… IVIG for fulminant myocarditis was not associated with lower in-hospital mortality. … Fulminant
myocarditis (FM) is a rare but life-threatening disease. … in the high dose group (Table 4). …

… number of randomized clinical trials have assessed the efficacy of immunosuppressive
therapies such as steroids, intravenous immunoglobulins (IVIG) or interferon on the resolution of …

… , especially those with fulminant myocarditis, require an … acute myocarditis (ie, giant cell
and eosinophilic myocarditis) … in patients with lymphocytic acute myocarditis, even though …

… fulminant myocarditis characterized by sudden onset of severe heart failure and LV dysfunction,
we administered high-dose IVIG … We experienced that early treatment of high-dose IVIG …

… Intravenous immunoglobulin (IVIG) has been associated with improved LV function and …
IVIG was used for FM treatment. Currently, no randomized, prospective trials implementing IVIG …

… , such as intravenous immunoglobulins (mostly used in … high doses of vasopressors or
LVAD. In this series, two patients with FM required MCS; the remaining received high-dose …